Publications based on CRC1479 funding
Rahbari M, Gris-Oliver A, Ramadori P, Aicher D, Sia D, Malek NP, Loomba R, Bataller R, Llovet JM, Heikenwälder M. The versatile interplay between steatotic liver disease and liver cancer. Nat Rev Cancer. 2026 Apr 14. doi: 10.1038/s41568-026-00918-y. Epub ahead of print.
Gawron J, Czech M, Rückert T, Holzmüller V, Andreev G, Burk AC, Hartmann A, Chatterjee S, Andrieux G, Marquard FE, Baur AS, Stell AV, Krausz M, Braun LM, Osswald N, Melchinger W, Wertheimer T, Proano-Vasco AI, Maas-Bauer K, Schmitt-Graeff A, Boerries M, Köhler N, Ayuk FA, Schell C, Quante M, Zeiser R. Gastrin for the treatment of acute graft-versus-host disease of the stomach. Blood. 2026 Apr 9;147(15):1763-1778. doi: 10.1182/blood.2025031080.
Highlighted by: Chakraverty R. GVHD fails the acid test. Blood. 2026 Apr 9;147(15):1660-1662.
Maas-Bauer K, Meyer T, Yücel M, Garofalaki M, Koßmann S, Biavasco F, Lysandrou M, Waterhouse M, Feuchtinger T, Pfeifer D, Ingelfinger F, Wertheimer T, Duyster J, Ahn JS, Soiffer RJ, Finke J, Wäsch R, Spyridonidis A, Kim DDH, Wehr C, Zeiser R. Mutational landscape changes of AML in patients relapsing after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2026 Apr 3. doi: . Epub ahead of print.
Braun LM, Naidoo J, Zeiser R. Immune-mediated side effects of cancer immunotherapies. Blood. 2026 Mar 9:blood.2025030059. doi: 10.1182/blood.2025030059. Epub ahead of print.
Chhatbar C, Sankowski R, Schulz M, Shimizu T, Schwabenland M, Staszewski O, Scheiwe C, Nessler S, Borst K, Dumas AA, Trost E, Berchtold D, Brandão W, Mossad O, Dalmau Gasull A, Frosch M, Erny D, Diebold M, Guffart E, Ternka K, Guranda M, Vinnakota JM, Friesen M, Ouk K, Waltl I, LaMorte M, Hammond TR, Di Liberto G, Vincenti I, Kreutzfeldt M, Mughrabi IT, Al-Abed Y, Blank T, Meyer-Luehmann M, Crow YJ, Hagen N, Ofengeim D, Zeiser R, Kettwig M, Gärtner J, Meisel A, Schwemmle M, Kalinke U, Beck J, Bengsch B, Thimme R, Butovsky O, Seredenina T, Ransohoff RM, Quintana FJ, Kierdorf K, Merkler D, Stadelmann C, Priller J, Prinz M. A transcriptomic microglia taxonomy across mouse and human pathologies. Nat Immunol. 2026 Mar 25:10.1038/s41590-026-02472-z. doi: 10.1038/s41590-026-02472-z. Epub ahead of print.
Li X, Lebeaupin C, Kadianaki A, Druelle-Cedano C, Vesper N, Rennert C, Huguet-Pradell J, Gomez Ramos B, Fan C, Piecyk RS, Zizmare L, Ramadori P, Li L, Frick L, Qiu M, Zhang C, Martins Nascentes Melo L, Ranvir VP, Shen P, Hanselmann J, Kosla J, Fernández-Vaquero M, Vucur M, Baskaran P, Bao X, Coleman OI, Tang Y, Cetin M, Chen Z, Jang I, Del Prete S, Rahbari M, Zhang P, Pham TV, Hou Y, Sun A, Gu L, Kim LC, Rothermel U, Heide D, Ali A, Gallage S, Talvard-Balland N, Piqué-Gili M, Gris-Oliver A, Bevilacqua A, Schlicker L, Duffey A, Unger K, Szydlowska M, Hetzer J, Odom DT, Machauer T, Bucci D, Sant P, Lee JH, Rösler J, Meckelmann SW, Schreck J, Murray S, Simon MC, Nahnsen S, Schulze A, Ho PC, Jugold M, Breuhahn K, Mallm JP, Schirmacher P, Roth S, Rahbari N, Tschaharganeh DF, Roessler S, Goeppert B, Bengsch B, Andrieux G, Boerries M, Malek NP, Prinz M, Weber A, Zeiser R, Tamayo P, Bronsert P, Kurowski K, Thimme R, Yuan D, Carretero R, Luedde T, Pinyol R, Hartmann FJ, Karin M, Tasdogan A, Trautwein C, Mall M, Hofmann M, Llovet JM, Haller D, Kaufman RJ, Heikenwälder M. Activated ATF6α is a hepatic tumour driver restricting immunosurveillance. Nature. 2026 Mar;651(8106):796-807. doi: 10.1038/s41586-025-10036-8. Epub 2026 Feb 4.
Fetsch V, Schwöbel L, Ozyerli-Goknar E, Stell AV, Punta M, Plenge T, Klaus T, Gupta MK, Andrieux G, Shoumariyeh K, Pfeiffer S, Corrales E, Schlenke L, Baniadam H, Brandl SM, Andreis M, Remen M, Hartmann A, Grueter K, Zwick M, Köhler N, Kuban M, Metzger E, Rummelt C, Duyster J, Boerries M, Hofmann M, Färber J, Braun LM, Zähringer A, Lübbert M, Toffalori C, Vago L, Heidel FH, Minguet S, Apostolova P, Feuchtinger T, Maas-Bauer K, Blaeschke F, Kühn MWM, Timmers HTM, Wertheimer T, Perner F, Zeiser R. Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML. Blood. 2026 Jan 29;147(5):584-601. doi: 10.1182/blood.2025029712.
Highlighted by: Chakraverty R. Menin inhibitors: a 2-in-1 defense versus AML immune evasion. Blood (2026) 147 (5): 482–483.
Duque-Afonso J, Rummelt C, Förster K, Zeiser R, Mougiakakos D. BCMA-CD3 T-cell engager as salvage therapy for multirefractory primary immune thrombocytopenia. Lancet. 2026 Jan 23:S0140-6736(25)02515-2. doi: 10.1016/S0140-6736(25)02515-2. Epub ahead of print.
Traichel J, Metzger A, Walz M, Feuerstein R, Wohlfeil N, Metzger P, Marx L, Asdih C, Lindenthal A, Seger A, Schrimpf J, Nardella LL, Kowar S, Frew IJ, Halbach S, Kesselring R, Boerries M, Griffin R, Brummer T. Novel syngeneic cell lines for studying high-risk BRAFV600E-driven colorectal cancer in vivo. Cancer Res Commun. 2026 Jan 22. doi: 10.1158/2767-9764.CRC-25-0599. Epub ahead of print.
Gu J, Li Y, Chen Q, Song Z, Qian Q, Liang Y, Huang T, Qiao L, Li X, Yu M, Liu M, Zhou J, Shao Q, Xu X, Zeiser R, Lu L. Tumor-produced ammonia is metabolized by regulatory T cells to further impede anti-tumor immunity. Cell. 2026 Jan 22;189(2):418-434.e24. doi: 10.1016/j.cell.2025.11.034. Epub 2025 Dec 24.
Hafner P, Keller SJ, Chen X, Alrawashdeh A, Jumaa H, Nollmann FI, Besson S, Kemming J, Gorka O, Das T, Appiah B, Lehmann A, Li M, Apostolova P, Bengsch B, Zeiser R, Tholen S, Schilling O, Groß O, Vlachos A, Wittel UA, von Elverfeldt D, Reichardt W, Boerries M, Andrieux G, Heynen GJ, Fichtner-Feigl S, Hannibal L, Ruess DA. Vertical RAS pathway inhibition in pancreatic cancer drives therapeutically exploitable mitochondrial alterations. Signal Transduct Target Ther. 2026 Jan 16;11(1):33. doi: 10.1038/s41392-025-02563-7.
Zwick M, Zinkel B, Spohr C, Rückert T, Halbach S, Shoumariyeh K, Scheid J, Baur AS, Braun LM, Angel M, Michaeli E, Todkar A, Nelde A, Märklin M, Holzmayer SJ, Dicks S, Boerries M, Duquesne S, Schlaak AE, Otto-Mora P, Bengsch B, Schiff M, Kissel S, Selle M, Follo M, Altmann H, Kunadt D, Illert AL, Walz JS, Walz G, Duyster J, Schetelig J, Brummer T, Zeiser R, Köhler N. FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid Leukemia. Cancer Res. 2026 Jan 16;86(2):367-386. doi: 10.1158/0008-5472.CAN-25-0349.
Tangermann C, Ghosh A, Ziegler M, Facchinetti F, Stappenbeck J, Carus Sahin YO, Riester M, Viardot LC, Zundel T, Friboulet L, Hollebecque A, Naveja JJ, Wanninger A, Hess ME, Brummer T, Boerries M, Loges S, Loriot Y, Illert AL, Diederichs S. Saturation mutagenesis identifies activating and resistance-inducing FGFR kinase domain mutations. Nat Genet. 2026 Jan;58(1):157-168. doi: 10.1038/s41588-025-02431-8. Epub 2025 Dec 8.
Braun LM, Zeiser R. Cutting without cleaving: How caspase-1 shapes leukemia beyond enzymatic activity. Cell Chem Biol. 2026 Jan 15;33(1):1-3. doi: 10.1016/j.chembiol.2025.12.011.
Watter M, Giuliani C, Benadi G, Engel F, Binder H, Kaier K. Automated identification of contextually relevant biomedical entities with grounded LLMs. Sci Rep. 2026 Jan 13;16(1):1952. doi: 10.1038/s41598-026-35492-8.
Kaier K, Engel F, Benadi G, Giuliani C, Watter M, Kalantari A, Schuller K, Franzke CW, Sperandio M, Binder H. Identification of biomedical entities from multiple repositories using a specialized metadata schema and search-augmented large language models. BMC Res Notes. 2026 Jan 12;19(1):43. doi: 10.1186/s13104-026-07632-w.PMC12837611.
———————————————— start of second funding periode ————————————————–
Bakırdöğen D, Görgülü K, Xin J, Richter L, Alcalá S, Ruiz-Cañas L, Dai C, Frank KJ, Wu N, Diakopoulos KN, Ozturk H, Demircioğlu D, Peschke K, Ranjan R, Fusco F, Martinez-Useros J, Fernandez-Aceñero MJ, Chhabra NF, López-Gil JC, Ai J, Ruess DA, Kaya-Aksoy E, Schmidt F, Kohlmann L, Berninger A, Yangin H, Schicktanz F, Steiger K, Demir IE, Schmid RM, Reichert M, Adli M, Lesina M, Sainz B Jr, Algül H. c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance and EMT. Mol Cancer. 2025 Dec 15. doi: 10.1186/s12943-025-02486-5. Epub ahead of print.
Giuliani C, Benadi G, Engel F, Werner J, Watter M, Schwarzer G, Groß O, Zeiser R, Binder H, Kaier K. Identifying Biomedical Entities for Datasets in Scientific Articles: 4-Step Cache-Augmented Generation Approach Using GPT-4o and PubTator 3.0. JMIR Form Res. 2025 Nov 20;9:e73822. doi: 10.2196/73822.
Lalioti ME, Romero-Mulero MC, Karabacz N, Mess J, Demollin H, Rettkowski J, Schuldes K, Mitterer M, Wadle C, Shoumariyeh K, Egg M, Alfonso-Gonzalez C, Jäcklein K, Schönberger K, Karantzelis N, Reisig G, Aktories P, Mayer IM, Tsoukala I, Schäffer A, Tirado-Gonzalez I, Dugourd A, Braun LM, Silva-Rego B, Jones MJ, Kierdorf K, Saez-Rodriguez J, Reising K, Walter SG, Medyouf H, Hilgers V, Ghiaur G, Zeiser R, Karpova D, Renders S, Gravius S, Buescher J, Cabezas-Wallscheid N. Differentiation, ageing and leukaemia alter the metabolic profile of human bone marrow haematopoietic stem and progenitor cells. Nat Cell Biol. 2025 Jul 15. doi: 10.1038/s41556-025-01709-7. Epub ahead of print.
